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ﬁelds of view showing an intermediate to high amount of extracel-
lular iron aggregates compared to ferucarbotran in both cell-types
(11.1 - 19.3% vs 47.6 - 57.2%) (Figure 1C, D).
Conclusions:We have shown that ferumoxides-protamine is more
effective and speciﬁc compared to ferucarbotran for labelling of
hBMSCs and chondrocytes using SPIO. In order to verify the
effectiveness and safety of cell therapies for cartilage repair, this
provides major opportunities for clinically applicable cell tracking
in an intra-articular environment.
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Purpose: The efﬁciency of cartilage regeneration is thought to
be highly affected by the chemical and mechanical properties
of engineered cartilage before implantation. The physicochemical
properties of cartilage implants go through the biological matura-
tion and structural remodeling after implantation as well as during
the engineering process.
The purpose of present study was to evaluate the maturity and
remodeling of a scaffold-free chondrocytes aggregates from young
human sources in vitro and ex vivo using explants of human
femoral condyle.
Methods: 1. Cell source and the scaffold-free system: Human
chondrocytes were isolated from the polydactyly tissues from 3
patients (1or 2 years old) and cultured in our scaffold-free cartilage
fabrication system, previously described. The fabricated scaffold-
free chondrocytes aggregate was cultivated in vitro for 1, 7, 21,
and 35 days before various assays. 2. Ex vivo cartilage tissue
regeneration system: Full thickness osteochondral defect (d = 5
mm) was created in the explant of human lateral femoral condyle
from 5 patients undertaken joint replacement surgery (age range
of 64-74 years). The defects of explants were left empty as a
negative control (group 1) or ﬁlled with the scaffold-free chondro-
cytes aggregate cultured for 7 days in vitro by press-ﬁtting method
(group 2). The autologous osteochondral tissue (AOTS) was used
as a positive control group (group 3). The explants with each
construct were implanted subcutaneously into the back of nude
mice and incubated for 4 weeks. 3. Evaluation of the fabricated
constructs in vitro and ex vivo: The scaffold-free chondrocytes
aggregate fabricated in vitro and ex vivo were evaluated by macro-
scopic observation, quantitative biochemical analysis, histological
assays and mechanical test. The ratio between the contents of
chondroitin sulfate-4 and -6 were also evaluated.
Results: In the static culture system in vitro, the scaffold-free
chondrocyte aggregate formed a white disk-shape construct with
rather irregular surface at all time points until 35 days. However, the
amount of GAG and collagen increased until 21 days and reached
plateau afterward. When the scaffold-free chondrocyte aggregate
cultured for 7 days in vitro was implanted into the ex vivo model,
both of the contents of biochemical components (DNA, GAG and
collagen) and mechanical strength were signiﬁcantly higher than
those cultured in vitro for 35 days and were more than 50% of
those of native cartilage tissues. The histochemical observations
showed positive staining of sulfated proteoglycans and type II
collagen although they were not as strong as those of native
tissues. In the Safranin-O staining, it appeared integrated with
host tissues better than AOTS group did. Furthermore a little bit
of collagen ﬁber formation was also observed in the Sirius red
staining.
Conclusions: In the present study, we showed that the scaffold-
free aggregates of human polydyctyly chondrocytes were fabri-
cated well into the cartilage-like structure in vitro and ex vivo in the
histochemcial, biochemical and mechanical analyses. This result
suggests that our scaffold-free fabrication system using young
human chondrocytes could be a potential treatment to regener-
ate the cartilage defect in human. To our knowledge, this is the
ﬁrst report to apply chondrocytes from polydactyly patients to the
scaffold-free system for cartilage regeneration.
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Purpose: In the past years attention has been focused on the
promising technology of cell-assisted repair that propose the use
of autologous chondrocytes for the treatment of cartilage lesions
due to traumatic events. The opportunity to enlarge the indications
to the treatment of early degenerative changes in OA patients is
very intriguing. Even if the use of MSCs as a pure cell lineage
has been advocated for cartilage repair to overcome problems
associated with donor-site morbidity, cell de-differentiation and
the limited lifespan of chondrocytes, the opportunity to implant
concentrated bone marrow in a single operative procedure is of
great importance. The rationale lies in the key role of bone marrow
microenvironment (or“niche”) which contains not only stem cells
and precursors cells as a source of regeneration tissue, but also
accessory cells that support angiogenesis and vasculogenesis by
producting several growth factors and cytokines.
Aim of the research was directed toward the conduction of an
in vitro study to characterize human concentrated bone marrow-
derived cells (BMDc) and their ability to differentiate into cartilage
and bone.
Methods: Human bone marrow was obtained from the posterior
iliac crest of patients underwent autologous cell transplantation
for osteochondral defects and directly concentrated in operative
room by a cell separator. To characterize BMDc a series of
cellular markers has been evaluated using monoclonal antibodies
anti- CD45, CD34, CD54, CD63, CD90, CD105, CD106, CD146,
CD271 by ﬂow cytometric analysis. The ability of the cells to
form colonies was analized by CFU-F test. The potentiality of
concentrate cells to differentiate into chondrogenic and osteogenic
lineages was analyzed after culturing the cells up to 28 days in
differentiating media and evaluated by Alcian Blue and Alizarin red
S staining.
Results: BMDc expressed CD34, CD45, CD54 and CD63 at
the same levels as isolated MSCs, while CD90, CD105, CD106,
CD146 and CD271 were highly expressed in BMDc compared
to MSCs. BMDc were able to form colonies and once they are
cultured in chondrogenic medium added with TGFβ were positive
for Alcian Blue staining on day 28 showing the presence of
extracellular matrix speciﬁc molecules. At the same experimental
time, a lot of colonies positive to Alizarin red S in BMDc cultured in
osteogenic medium were found. Calcium precipitates were evident
inside the colonies.
Conclusions: Bone and cartilage defects are common features of
joint diseases in OA. Despite progress in orthopaedic surgery, the
repair of these tissues is a major challenge as they do not sponta-
neously heal. The chance to use autologous cell transplantation in
degenerative lesions in OA patients represents an important ther-
apeutical strategy for the disease. Patients could beneﬁt of such
